19
Incyte Corporation, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA.
One of their notable products is RUXOLITINIB PHOSPHATE, with a corresponding application number 202192.
Regulatory Information RX
With a dosage strength EQ 10MG BASE
Dosage Form Route TABLET; ORAL
Reference Listed Drug Yes
Approved since 2011-11-16
18
Incyte Corporation, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA.
One of their notable products is RUXOLITINIB PHOSPHATE, with a corresponding application number 202192.
Regulatory Information RX
With a dosage strength EQ 25MG BASE
Dosage Form Route TABLET; ORAL
Reference Listed Drug Yes
Approved since 2011-11-16
17
Incyte Corporation, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA.
One of their notable products is RUXOLITINIB PHOSPHATE, with a corresponding application number 202192.
Regulatory Information RX
With a dosage strength EQ 15MG BASE
Dosage Form Route TABLET; ORAL
Reference Listed Drug Yes
Approved since 2011-11-16
16
Incyte Corporation, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA.
One of their notable products is RUXOLITINIB PHOSPHATE, with a corresponding application number 202192.
Regulatory Information RX
With a dosage strength EQ 5MG BASE
Dosage Form Route TABLET; ORAL
Reference Listed Drug Yes
Approved since 2011-11-16
15
Incyte Corporation, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA.
One of their notable products is RUXOLITINIB PHOSPHATE, with a corresponding application number 202192.
Regulatory Information RX
With a dosage strength EQ 20MG BASE
Dosage Form Route TABLET; ORAL
Reference Listed Drug Yes
Approved since 2011-11-16